A detailed history of Moloney Securities Asset Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 10,808 shares of NVO stock, worth $947,321. This represents 0.18% of its overall portfolio holdings.

Number of Shares
10,808
Previous 14,911 27.52%
Holding current value
$947,321
Previous $2.13 Million 39.57%
% of portfolio
0.18%
Previous 0.32%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$119.07 - $145.42 $488,544 - $596,658
-4,103 Reduced 27.52%
10,808 $1.29 Million
Q2 2024

Jul 30, 2024

BUY
$122.71 - $146.91 $241,738 - $289,412
1,970 Added 15.22%
14,911 $2.13 Million
Q1 2024

May 01, 2024

BUY
$102.11 - $135.92 $84,444 - $112,405
827 Added 6.83%
12,941 $1.66 Million
Q4 2023

Jan 30, 2024

SELL
$87.78 - $105.45 $4,389 - $5,272
-50 Reduced 0.41%
12,114 $1.25 Million
Q3 2023

Oct 31, 2023

BUY
$90.94 - $199.54 $525,815 - $1.15 Million
5,782 Added 90.6%
12,164 $1.11 Million
Q2 2023

Jul 31, 2023

BUY
$155.98 - $172.65 $7,954 - $8,805
51 Added 0.81%
6,382 $1.03 Million
Q1 2023

May 12, 2023

SELL
$132.34 - $159.14 $149,147 - $179,350
-1,127 Reduced 15.11%
6,331 $1.01 Million
Q4 2022

Jan 30, 2023

SELL
$102.55 - $135.33 $17,741 - $23,412
-173 Reduced 2.27%
7,458 $1.01 Million
Q3 2022

Oct 31, 2022

SELL
$95.28 - $116.93 $100,044 - $122,776
-1,050 Reduced 12.1%
7,631 $760,000
Q2 2022

Aug 03, 2022

SELL
$103.24 - $121.81 $20,648 - $24,362
-200 Reduced 2.25%
8,681 $967,000
Q1 2022

May 10, 2022

BUY
$93.1 - $112.54 $12,196 - $14,742
131 Added 1.5%
8,881 $986,000
Q4 2021

Jan 28, 2022

SELL
$95.88 - $117.08 $19,176 - $23,416
-200 Reduced 2.23%
8,750 $980,000
Q3 2021

Oct 27, 2021

SELL
$84.42 - $106.62 $139,293 - $175,923
-1,650 Reduced 15.57%
8,950 $859,000
Q1 2021

Apr 28, 2021

SELL
$67.06 - $75.82 $6,706 - $7,581
-100 Reduced 0.93%
10,600 $715,000
Q4 2020

Feb 08, 2021

SELL
$63.89 - $73.8 $15,333 - $17,712
-240 Reduced 2.19%
10,700 $747,000
Q2 2020

Jul 31, 2020

SELL
$58.54 - $67.94 $19,610 - $22,759
-335 Reduced 2.97%
10,940 $716,000
Q1 2020

May 08, 2020

SELL
$49.46 - $64.78 $9,892 - $12,956
-200 Reduced 1.74%
11,275 $679,000
Q3 2019

Nov 01, 2019

SELL
$47.54 - $53.43 $12,978 - $14,586
-273 Reduced 2.32%
11,475 $593,000
Q2 2019

Jul 29, 2019

BUY
$46.79 - $52.47 $15,487 - $17,367
331 Added 2.9%
11,748 $600,000
Q1 2019

May 03, 2019

SELL
$46.36 - $52.63 $61,705 - $70,050
-1,331 Reduced 10.44%
11,417 $597,000
Q3 2018

Oct 24, 2018

BUY
$46.76 - $51.24 $4,676 - $5,124
100 Added 0.79%
12,748 $0
Q2 2018

Jul 26, 2018

SELL
$44.29 - $50.42 $95,223 - $108,403
-2,150 Reduced 14.53%
12,648 $583,000
Q1 2018

Apr 25, 2018

SELL
$48.49 - $58.14 $67,886 - $81,396
-1,400 Reduced 8.64%
14,798 $729,000
Q4 2017

Jan 25, 2018

SELL
$47.53 - $53.73 $114,072 - $128,951
-2,400 Reduced 12.9%
16,198 $869,000
Q3 2017

Oct 18, 2017

BUY
$41.15 - $49.22 $765,307 - $915,393
18,598
18,598 $895,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Moloney Securities Asset Management, LLC Portfolio

Follow Moloney Securities Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.